FDA DEVICE FACTS
Mobio Total Knee System
B-One Ortho, Corp.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The MOBIO Total Knee System is intended for total knee arthroplasty due to the following conditions: ɾPainful, disabling joint disease of the knee resulting from: noninflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post -traumatic arthritis ɾPost-traumatic loss of knee joint configuration and function ɾModerate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability. ɾRevision of previous unsuccessful knee replacement or other procedure ɾFracture of the distal femur and/or proximal tibia that cannot be stabilized by standard fracture- management techniques Additional Indications for the Posterior Stabilized (PS) and Posterior Stabilized Plus (PS+): ɾLigamentous instability requiring implant bearing surface geometries with increased constraint ɾAbsent or nonfunctioning posterior cruciate ligament ɾSevere anteroposterior instability of the knee joint The MOBIO Total Knee System is intended for implantation with bone cement only. MOBIO Total Knee System components are not intended for use with other knee systems.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。